Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events

Peer Review reports

Original Submission
18 Sep 2019	Submitted	Original manuscript
4 Dec 2019	Reviewed	Reviewer Report - Sarah Jackson
6 Dec 2019	Reviewed	Reviewer Report - Jian Zheng
16 Dec 2019	Author responded	Author comments - Ralph Rogers
Resubmission - Version 2
16 Dec 2019	Submitted	Manuscript version 2
7 Jan 2020	Author responded	Author comments - Ralph Rogers
Resubmission - Version 3
7 Jan 2020	Submitted	Manuscript version 3
Publishing
9 Jan 2020	Editorially accepted
17 Jan 2020	Article published	10.1186/s12879-020-4787-4

Back to article page